HOME >> BIOLOGY >> NEWS
Pioneering experiments testing effects of greenhouse gases on crops

CHAMPAIGN, Ill. Portions of 40 acres of University of Illinois farmland this summer are sprouting soybeans grown in the presence of carbon dioxide levels forecast for the year 2050. Next summer, elevated levels of ozone will join the mix in a first-of-its-kind experiment called SoyFACE.

"When you consider the importance of the Midwest in terms of global food security, it is important to do this research here," said Stephen P. Long, a photosynthesis expert and the Robert Emerson Professor of Plant Biology at the UI. "Up to now, experiments related to global warming on many crops have been done in locations on the periphery of major food production areas."

Researchers want to know how soybeans may be affected, and what scientists might do to assure the integrity of yields and quality as the climate changes. By 2050, carbon dioxide levels are expected to be about 1.5 times greater than the current 370 parts per million, while daytime ozone levels during the growing season could peak on average at 80 parts per billion (now 60 parts per billion).

SoyFACE (Free Air gas Concentration Enrichment) is the first test of crop growth in the presence of both increased carbon dioxide and ozone. Five UI departments, the USDA-ARS and Illinois State Water Survey, as well as researchers from four other nations and two other U.S. universities are participating this summer.

Four control and four experimental 70-foot-diameter rings currently surround 24 varieties of soybeans. The experimental rings have ABS plastic pipes that deliver at crop level a precisely regulated flow of carbon dioxide, based on wind speed and direction, pumped from a 50-ton solar-powered tank.

Next summer, soybeans will grow on an adjacent 40 acres dotted with 24 of the octagon-shaped rings. Four rings will pump carbon dioxide, four will provide just ozone and four will provide ozone and carbon dioxide. Natural conditions will exist in an equal number of control rings for each test
'"/>

Contact: Jim Barlow
b-james3@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
2-Jul-2001


Page: 1 2

Related biology news :

1. Pioneering AIDS researcher to speak at UH
2. Pioneering discoveries, pursuing new knowledge, fostering partnerships
3. Pioneering flu researcher wins major Imperial scientific award
4. Pioneering study compares 13 vertebrate genomes
5. UFS Mcknight Brain Institute researchers: Pioneering spinal cord procedure appears safe
6. Pioneering evolutionist Ledyard Stebbins dies at age 94
7. Pioneering Research Could Lead To Treatment
8. Sandia experiments may reduce possibility of future water wars
9. APS recognizes Intel high school finalists for experiments in physiology
10. BioScience seeks nominations of beauteous experiments
11. ALife experiments show how complex functions can evolve

Post Your Comments:
(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , a ... today announced that Murali Prahalad , Ph.D., president and ... World Conference (PMWC) 2015: Silicon Valley, which is taking ... View, Calif. on January 26-28, 2015. ... of Age as Biomarkers." Last year, Epic Sciences was a ...
(Date:2/5/2015)... 2015 New Market Research Reports ... Forecasts To 2020 has Been Added to GrandViewReseach.com Report ... expected to reach USD 5.10 billion by 2020, according ... IR cameras help identify the site of tissue damage ... surging demand in medical imaging applications. They have been ...
(Date:2/5/2015)... 30, 2015  It is gratifying to see that ... for genomic science as a means to better understand ... treatment.  I was honored to participate in today,s White ... program. Since the 1980s my teams ... the first sequenced genome of a free living organism, ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
(Date:2/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... fiscal first quarter ended December  31, 2014. All figures ... unless otherwise stated. "During the quarter ... existing customers and add to our sales pipeline," said ...
(Date:2/26/2015)... Feb. 26, 2015 Protiviti ( www.protiviti.com ), ... of the Governance Portal , designed to increase ... compliance (GRC) tasks across multiple business units and projects. ... help customers better align their controls with the COSO ... ) requirements. In response to client feedback, Protiviti has ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
Cached News: